IHS Chemical Week

World News and Views :: Top of the News

Sanofi-Aventis to Acquire Genzyme for $20.1 Billion

11:59 PM MST | February 15, 2011 | Deepti Ramesh

Sanofi-Aventis says it has entered into a definitive agreement with biotechnology company Genzyme (Cambridge, MA), under which Sanofi-Aventis will acquire Genzyme for $74/share in cash, or about $20.1 billion. The transaction, which has been approved by the boards of directors of both companies, is expected to close early in the second quarter of 2011. The combination will enhance Sanofi-Aventis’ growth strategy by expanding its footprint in biotechnology, Sanofi-Aventis says. Genzyme, since 1981, has grown from a small start-up to a diversified enterprise...

This information is only available to Chemical Week subscribers.

Username:
Password:

Forgot your user ID or password?
Click here to have it sent to you.



Not an IHS Chemical Week member yet?

Here's why you should be:

  • 31 issues of Chemical Week magazine in print or digital format
  • Critical daily news and analysis on chemweek.com
  • Free mobile edition 
  • 20+ years of online archives
  • Topical e-newsletters that capture the most impactful events
  • Special issues with a regional or company focus
  • Global Outlook issue

Subscribe now

100% Satisfaction Guarantee
If at any time you are not completely satisfied with IHS Chemical Week, simply notify us and we'll refund the balance of your paid subscription - no problem.

Learn more about group subscriptions and site licenses.

 














 
contact us | about us | customer care | privacy policy | sitemap | advertise

ihsCopyright © 2015 IHS, Inc. All rights reserved. Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa